Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Novel orally active antithrombotic agent from Fuji Yakuhin

March 27, 1997

Novel antipsychotic agent reported by Asahi Chemical

March 26, 1997

Daiichi Pharmaceutical presents novel antisecretory agent

March 25, 1997

Novel positive inotrope discovered by Meiji Institute of Health Science

March 25, 1997

Tokyo University researchers characterize new steroidal saponin

March 25, 1997

Santen characterizes dual NEP/ACE inhibitor

March 24, 1997

Fujisawa describes compound for autoimmune diseases

March 24, 1997

New antiinflammatory agent from Yakult Honsha

March 24, 1997

Dainippon presents broad-spectrum antiemetic agent

March 24, 1997

Fujisawa presents selective, nonpeptide thrombin receptor inhibitor

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...